| 1 | https://labn.org/los-angeles-biotech-news/2024/07/30/nervonik-receives-regulatory-approval-to-start-first-in-human-study-with-novel-peripheral-nerve-stimulation-technology-for-chronic-pain/?utm_source=rss&utm_medium=rss&utm_campaign=aadi-bioscience-to-report-second-quarter-2024-results-and-corporate-update
| Whois | labn.org |
| 2 | https://labn.org/los-angeles-biotech-news/2024/07/29/newamsterdam-succeeds-in-the-first-of-three-key-pivotal-studies-providing-hope-to-a-troubled-cardio-class/?utm_source=rss&utm_medium=rss&utm_campaign=aadi-bioscience-to-report-second-quarter-2024-results-and-corporate-update
| Whois | labn.org |
| 3 | https://labn.org/los-angeles-biotech-news/2024/07/26/opinion-medtech-compliance-not-regulation-is-stifling-innovation/?utm_source=rss&utm_medium=rss&utm_campaign=aadi-bioscience-to-report-second-quarter-2024-results-and-corporate-update
| Whois | labn.org |
| 4 | https://labn.org/los-angeles-biotech-news/2024/07/24/biogennix-launches-agilon-surgical-matrix/?utm_source=rss&utm_medium=rss&utm_campaign=aadi-bioscience-to-report-second-quarter-2024-results-and-corporate-update
| Whois | labn.org |
| 5 | https://labn.org/los-angeles-biotech-news/2024/07/24/decode-genetics-variants-in-the-genome-affect-dna-methylation/?utm_source=rss&utm_medium=rss&utm_campaign=aadi-bioscience-to-report-second-quarter-2024-results-and-corporate-update
| Whois | labn.org |
| 6 | https://labn.org/los-angeles-biotech-news/2024/07/23/statement-from-emily-robinson-attorney-for-alison-chao/?utm_source=rss&utm_medium=rss&utm_campaign=aadi-bioscience-to-report-second-quarter-2024-results-and-corporate-update
| Whois | labn.org |
| 7 | https://labn.org/los-angeles-biotech-news/2024/07/23/microvention-announces-release-of-clinical-evaluation-of-web-17-device-in-intracranial-aneurysms-clever-one-year-effectiveness-results-for-ruptured-and-unruptured-aneurysms/?utm_source=rss&utm_medium=rss&utm_campaign=aadi-bioscience-to-report-second-quarter-2024-results-and-corporate-update
| Whois | labn.org |
| 8 | https://labn.org/los-angeles-biotech-news/2024/07/19/gro-biosciences-raises-60m-for-protein-therapies-from-genomically-recoded-organisms/?utm_source=rss&utm_medium=rss&utm_campaign=aadi-bioscience-to-report-second-quarter-2024-results-and-corporate-update
| Whois | labn.org |
| 9 | https://labn.org/los-angeles-biotech-news/2024/07/16/catalym-raises-150m-in-series-d-to-repurpose-obesity-target-for-cancer/?utm_source=rss&utm_medium=rss&utm_campaign=aadi-bioscience-to-report-second-quarter-2024-results-and-corporate-update
| Whois | labn.org |
| 10 | https://labn.org/los-angeles-biotech-news/2020/04/06/sec-qualifies-originclear-reg-a-public-offering/?utm_source=rss&utm_medium=rss&utm_campaign=aadi-bioscience-to-report-second-quarter-2024-results-and-corporate-update
| Whois | labn.org |
| 11 | https://sfbn.org/san-francisco-biotech-news/2024/07/31/s-f-biotech-company-to-cut-75-of-staff-after-clinical-trial-failures/
| Whois | sfbn.org |
| 12 | https://sfbn.org/san-francisco-biotech-news/2024/07/30/verily-to-relocate-its-hq-from-san-francisco-to-dallas/
| Whois | sfbn.org |
| 13 | https://sfbn.org/san-francisco-biotech-news/2024/07/30/day-ones-175m-pipe-pinetree-raises-17m-in-series-a/
| Whois | sfbn.org |
| 14 | https://sfbn.org/san-francisco-biotech-news/2024/07/30/montara-therapeutics-co-founded-by-ucsfs-kevan-shokat-to-develop-new-neuro-drugs/
| Whois | sfbn.org |
| 15 | https://sfbn.org/san-francisco-biotech-news/2024/07/24/peninsula-biotech-lines-up-employees-for-stock-bonuses-triggered-by-fda-decisions/
| Whois | sfbn.org |
| 16 | https://sfbn.org/san-francisco-biotech-news/2024/07/22/peninsula-biotech-to-cut-40-of-staff-as-it-awaits-analysis-of-halted-clinical-trial/
| Whois | sfbn.org |
| 17 | https://sfbn.org/san-francisco-biotech-news/2024/07/11/filmmaker-brings-into-focus-life-of-pioneering-transgender-womens-rights-neuroscientist-ben-barres/
| Whois | sfbn.org |
| 18 | https://sfbn.org/san-francisco-biotech-news/2024/04/11/magnetic-insight-announces-new-ceo-3-million-in-new-grant-funding/
| Whois | sfbn.org |
| 19 | https://sfbn.org/san-francisco-biotech-news/2024/03/11/biotech-networks-speed-networking-san-francisco-july-17th-2024/
| Whois | sfbn.org |
| 20 | https://sfbn.org/san-francisco-biotech-news/2023/11/14/biotech-networks-speed-networking-san-francisco-jpm-january-8th-2024/
| Whois | sfbn.org |
| 21 | https://sdbn.org/san-diego-biotech-news/2024/07/31/precision-oncology-via-artificial-intelligence-on-cancer-biopsies/
| Whois | sdbn.org |
| 22 | https://sdbn.org/san-diego-biotech-news/2024/07/31/takeda-defends-alzheimers-pact-tyk2-potential-as-restructuring-is-in-full-swing/
| Whois | sdbn.org |
| 23 | https://sdbn.org/san-diego-biotech-news/2024/07/31/ideaya-and-biocytogen-ink-400m-deal-daiichi-spends-more-on-superstar-adcs/
| Whois | sdbn.org |
| 24 | https://sdbn.org/san-diego-biotech-news/2024/07/31/tracon-winds-down-weeks-after-worlds-first-injectable-pd-l1-inhibitor-stumbles-in-phase-2/
| Whois | sdbn.org |
| 25 | https://sdbn.org/san-diego-biotech-news/2024/07/31/bracco-imaging-s-p-a-and-burl-concepts-inc-form-strategic-partnership-to-revolutionize-stroke-care/
| Whois | sdbn.org |
| 26 | https://sdbn.org/san-diego-biotech-news/2024/07/30/heron-therapeutics-to-report-second-quarter-2024-financial-results-on-tuesday-august-6-2024/
| Whois | sdbn.org |
| 27 | https://sdbn.org/san-diego-biotech-news/2024/07/30/extreme-heat-in-india-a-crisis-on-the-rise/
| Whois | sdbn.org |
| 28 | https://sdbn.org/san-diego-biotech-news/2024/07/30/illicit-fentanyl-use-linked-to-increased-risk-of-hepatitis-c-among-people-who-use-drugs/
| Whois | sdbn.org |
| 29 | https://sdbn.org/san-diego-biotech-news/2024/07/30/unlocking-the-power-of-large-language-models-from-neural-network-basics-to-biopharma-industry-transformation/
| Whois | sdbn.org |
| 30 | https://sdbn.org/san-diego-biotech-news/2024/07/30/uc-san-diego-reports-1-73-billion-in-research-awards-for-fy24/
| Whois | sdbn.org |
| 31 | https://txbn.org/texas-biotech-news/2024/07/25/baylor-college-of-medicine-completes-first-human-implantation-of-new-artificial-heart/?utm_source=rss&utm_medium=rss&utm_campaign=texas-childrens-hospital-receives-ratings-downgrade-after-medicaid-changes
| Whois | txbn.org |
| 32 | https://txbn.org/texas-biotech-news/2024/07/25/humana-division-to-fill-walmart-clinic-space-in-dfw-elsewhere/?utm_source=rss&utm_medium=rss&utm_campaign=texas-childrens-hospital-receives-ratings-downgrade-after-medicaid-changes
| Whois | txbn.org |
| 33 | https://txbn.org/texas-biotech-news/2024/07/23/fuzionaire-theranostics-welcomes-li-boynton-to-board-of-directors-and-klaus-kopka-to-advisory-board/?utm_source=rss&utm_medium=rss&utm_campaign=texas-childrens-hospital-receives-ratings-downgrade-after-medicaid-changes
| Whois | txbn.org |
| 34 | https://txbn.org/texas-biotech-news/2024/05/07/high-growth-i-35-hospital-lands-new-ceo-via-vegas/?utm_source=rss&utm_medium=rss&utm_campaign=texas-childrens-hospital-receives-ratings-downgrade-after-medicaid-changes
| Whois | txbn.org |
| 35 | https://txbn.org/texas-biotech-news/2024/03/14/study-gilead-antiviral-drug-shows-promise-as-a-treatment-for-ebola-sudan/?utm_source=rss&utm_medium=rss&utm_campaign=texas-childrens-hospital-receives-ratings-downgrade-after-medicaid-changes
| Whois | txbn.org |
| 36 | https://txbn.org/texas-biotech-news/2024/02/15/hlth-code-launches-complete-meal-plant-based-shake-for-vegans-and-vegetarians/?utm_source=rss&utm_medium=rss&utm_campaign=texas-childrens-hospital-receives-ratings-downgrade-after-medicaid-changes
| Whois | txbn.org |
| 37 | https://txbn.org/texas-biotech-news/2024/01/29/medical-device-co-autonomix-medical-begins-trading-on-nasdaq-after-11-2m-ipo/?utm_source=rss&utm_medium=rss&utm_campaign=texas-childrens-hospital-receives-ratings-downgrade-after-medicaid-changes
| Whois | txbn.org |
| 38 | https://txbn.org/texas-biotech-news/2024/01/19/bizspotlight-avanza-healthcare-strategies/?utm_source=rss&utm_medium=rss&utm_campaign=texas-childrens-hospital-receives-ratings-downgrade-after-medicaid-changes
| Whois | txbn.org |
| 39 | https://txbn.org/texas-biotech-news/2024/01/12/assets-of-closed-st-camillus-medical-center-will-be-sold-at-auction/?utm_source=rss&utm_medium=rss&utm_campaign=texas-childrens-hospital-receives-ratings-downgrade-after-medicaid-changes
| Whois | txbn.org |
| 40 | https://txbn.org/texas-biotech-news/2023/12/15/mouthwatering-new-addition-le-vel-announces-myfresh-meals-nationwide-farm-to-table-meal-delivery/?utm_source=rss&utm_medium=rss&utm_campaign=texas-childrens-hospital-receives-ratings-downgrade-after-medicaid-changes
| Whois | txbn.org |
| 41 | https://ucbn.org/utah-colorado-biotech-news/2024/07/31/colorado-bioscience-association-highlights-investment-opportunities-at-the-2024-rocky-mountain-life-sciences-investor-partnering-conference/?utm_source=rss&utm_medium=rss&utm_campaign=arieli-capital-joins-induction-bio-as-a-partner-and-announces-the-establishment-of-the-induction-reproductive-health-studio-ideas
| Whois | ucbn.org |
| 42 | https://ucbn.org/utah-colorado-biotech-news/2024/07/29/these-colorado-ceos-saw-the-largest-jumps-in-their-pay-last-year/?utm_source=rss&utm_medium=rss&utm_campaign=arieli-capital-joins-induction-bio-as-a-partner-and-announces-the-establishment-of-the-induction-reproductive-health-studio-ideas
| Whois | ucbn.org |
| 43 | https://ucbn.org/utah-colorado-biotech-news/2024/07/29/denver-co-spent-millions-to-make-a-cancer-drug-it-cant-sell-but-its-growing-anyway/?utm_source=rss&utm_medium=rss&utm_campaign=arieli-capital-joins-induction-bio-as-a-partner-and-announces-the-establishment-of-the-induction-reproductive-health-studio-ideas
| Whois | ucbn.org |
| 44 | https://ucbn.org/utah-colorado-biotech-news/2024/07/29/theralight-adds-360-model-to-existing-line-of-products/?utm_source=rss&utm_medium=rss&utm_campaign=arieli-capital-joins-induction-bio-as-a-partner-and-announces-the-establishment-of-the-induction-reproductive-health-studio-ideas
| Whois | ucbn.org |
| 45 | https://ucbn.org/utah-colorado-biotech-news/2024/07/29/dentists-may-be-the-secret-to-better-sleep/?utm_source=rss&utm_medium=rss&utm_campaign=arieli-capital-joins-induction-bio-as-a-partner-and-announces-the-establishment-of-the-induction-reproductive-health-studio-ideas
| Whois | ucbn.org |
| 46 | https://ucbn.org/utah-colorado-biotech-news/2024/07/25/zynex-reports-second-quarter-2024-financial-results/?utm_source=rss&utm_medium=rss&utm_campaign=arieli-capital-joins-induction-bio-as-a-partner-and-announces-the-establishment-of-the-induction-reproductive-health-studio-ideas
| Whois | ucbn.org |
| 47 | https://ucbn.org/utah-colorado-biotech-news/2024/07/17/waystar-to-announce-second-quarter-2024-financial-results-on-august-7-2024/?utm_source=rss&utm_medium=rss&utm_campaign=arieli-capital-joins-induction-bio-as-a-partner-and-announces-the-establishment-of-the-induction-reproductive-health-studio-ideas
| Whois | ucbn.org |
| 48 | https://ucbn.org/utah-colorado-biotech-news/2024/06/13/accure-acne-and-quanta-system-announce-commercial-partnership-in-the-eu-to-broaden-adoption-of-the-accure-laser/?utm_source=rss&utm_medium=rss&utm_campaign=arieli-capital-joins-induction-bio-as-a-partner-and-announces-the-establishment-of-the-induction-reproductive-health-studio-ideas
| Whois | ucbn.org |
| 49 | https://ucbn.org/utah-colorado-biotech-news/2023/07/20/fda-reports-shortage-of-novo-nordisks-weight-loss-drug-saxenda/?utm_source=rss&utm_medium=rss&utm_campaign=arieli-capital-joins-induction-bio-as-a-partner-and-announces-the-establishment-of-the-induction-reproductive-health-studio-ideas
| Whois | ucbn.org |
| 50 | https://ucbn.org/utah-colorado-biotech-news/2022/08/02/dr-jennifer-strickland-fowler-joins-destination-pet-as-ceo-to-lead-the-companys-next-phase-of-growth/?utm_source=rss&utm_medium=rss&utm_campaign=arieli-capital-joins-induction-bio-as-a-partner-and-announces-the-establishment-of-the-induction-reproductive-health-studio-ideas
| Whois | ucbn.org |
| 51 | https://wobn.org/washington-oregon-biotech-news/2024/07/30/new-funding-announced-for-revolutionary-disease-detection-technology/?utm_source=rss&utm_medium=rss&utm_campaign=twinstrand-biosciences-and-exact-sciences-announce-exclusive-license-agreement-for-duplex-sequencing-technology
| Whois | wobn.org |
| 52 | https://wobn.org/washington-oregon-biotech-news/2024/07/30/kirkland-company-ceo-looks-ahead-to-growth-after-giant-funding-round/?utm_source=rss&utm_medium=rss&utm_campaign=twinstrand-biosciences-and-exact-sciences-announce-exclusive-license-agreement-for-duplex-sequencing-technology
| Whois | wobn.org |
| 53 | https://wobn.org/washington-oregon-biotech-news/2024/07/29/seattle-startup-revealdx-lands-4-2m-to-help-clinicians-diagnose-lung-cancer/?utm_source=rss&utm_medium=rss&utm_campaign=twinstrand-biosciences-and-exact-sciences-announce-exclusive-license-agreement-for-duplex-sequencing-technology
| Whois | wobn.org |
| 54 | https://wobn.org/washington-oregon-biotech-news/2024/07/29/drug-developed-at-ohsu-attracts-100m-investment-round-for-biotech-company/?utm_source=rss&utm_medium=rss&utm_campaign=twinstrand-biosciences-and-exact-sciences-announce-exclusive-license-agreement-for-duplex-sequencing-technology
| Whois | wobn.org |
| 55 | https://wobn.org/washington-oregon-biotech-news/2024/07/25/ohsu-postdoc-researchers-vote-to-authorize-strike-over-scrimpy-wages-and-benefits/?utm_source=rss&utm_medium=rss&utm_campaign=twinstrand-biosciences-and-exact-sciences-announce-exclusive-license-agreement-for-duplex-sequencing-technology
| Whois | wobn.org |
| 56 | https://wobn.org/washington-oregon-biotech-news/2024/07/25/ohsu-taps-former-portland-state-hr-leader-as-interim-chief-people-officer/?utm_source=rss&utm_medium=rss&utm_campaign=twinstrand-biosciences-and-exact-sciences-announce-exclusive-license-agreement-for-duplex-sequencing-technology
| Whois | wobn.org |
| 57 | https://wobn.org/washington-oregon-biotech-news/2024/07/25/presage-biosciences-announces-first-patient-dosing-of-pure-biologics-ror1-targeting-antibody-for-treatment-of-cancer/?utm_source=rss&utm_medium=rss&utm_campaign=twinstrand-biosciences-and-exact-sciences-announce-exclusive-license-agreement-for-duplex-sequencing-technology
| Whois | wobn.org |
| 58 | https://wobn.org/washington-oregon-biotech-news/2024/07/24/kirkland-company-raises-196-million-for-wearable-defibrillator/?utm_source=rss&utm_medium=rss&utm_campaign=twinstrand-biosciences-and-exact-sciences-announce-exclusive-license-agreement-for-duplex-sequencing-technology
| Whois | wobn.org |
| 59 | https://wobn.org/washington-oregon-biotech-news/2024/07/24/palvellas-reverse-merger-with-pieris-abbvies-vc-arm-invests-in-anti-aging-startup/?utm_source=rss&utm_medium=rss&utm_campaign=twinstrand-biosciences-and-exact-sciences-announce-exclusive-license-agreement-for-duplex-sequencing-technology
| Whois | wobn.org |
| 60 | https://wobn.org/washington-oregon-biotech-news/2024/07/22/seattle-biotech-startup-bonum-therapeutics-upgrades-offices-expands-team-in-its-pursuit-of-cancer-drugs/?utm_source=rss&utm_medium=rss&utm_campaign=twinstrand-biosciences-and-exact-sciences-announce-exclusive-license-agreement-for-duplex-sequencing-technology
| Whois | wobn.org |
| 61 | https://mwbn.bio/midwest-life-science-news/2024/07/27/mapping-glp-1-game-plans-q2-earnings-highlights-j-and-more/?utm_source=rss&utm_medium=rss&utm_campaign=otsuka-and-lundbeck-present-new-rexulti-brexpiprazole-post-hoc-efficacy-data-analyses-for-agitation-associated-with-dementia-due-to-alzheimers-disease-at-alzheimers-associati
| Whois | mwbn.bio |
| 62 | https://mwbn.bio/midwest-life-science-news/2024/07/26/metrohealth-names-christine-alexander-rager-interim-president-and-ceo/?utm_source=rss&utm_medium=rss&utm_campaign=otsuka-and-lundbeck-present-new-rexulti-brexpiprazole-post-hoc-efficacy-data-analyses-for-agitation-associated-with-dementia-due-to-alzheimers-disease-at-alzheimers-associati
| Whois | mwbn.bio |
| 63 | https://mwbn.bio/midwest-life-science-news/2024/07/26/annual-friar-fight-to-end-duchenne-golf-tournament-celebrates-40-years/?utm_source=rss&utm_medium=rss&utm_campaign=otsuka-and-lundbeck-present-new-rexulti-brexpiprazole-post-hoc-efficacy-data-analyses-for-agitation-associated-with-dementia-due-to-alzheimers-disease-at-alzheimers-associati
| Whois | mwbn.bio |
| 64 | https://mwbn.bio/midwest-life-science-news/2024/07/25/abbvie-beats-expectations-with-smaller-humira-slide-and-big-gains-for-next-autoimmune-blockbusters/?utm_source=rss&utm_medium=rss&utm_campaign=otsuka-and-lundbeck-present-new-rexulti-brexpiprazole-post-hoc-efficacy-data-analyses-for-agitation-associated-with-dementia-due-to-alzheimers-disease-at-alzheimers-associati
| Whois | mwbn.bio |
| 65 | https://mwbn.bio/midwest-life-science-news/2024/07/25/newsmaker-mount-carmel-ceo-tauana-mcdonald-is-passionate-about-her-job-and-scrabble/?utm_source=rss&utm_medium=rss&utm_campaign=otsuka-and-lundbeck-present-new-rexulti-brexpiprazole-post-hoc-efficacy-data-analyses-for-agitation-associated-with-dementia-due-to-alzheimers-disease-at-alzheimers-associati
| Whois | mwbn.bio |
| 66 | https://mwbn.bio/midwest-life-science-news/2024/07/25/abbvie-expects-8-7b-cerevel-buy-to-close-as-early-as-next-week-new-ceo-says/?utm_source=rss&utm_medium=rss&utm_campaign=otsuka-and-lundbeck-present-new-rexulti-brexpiprazole-post-hoc-efficacy-data-analyses-for-agitation-associated-with-dementia-due-to-alzheimers-disease-at-alzheimers-associati
| Whois | mwbn.bio |
| 67 | https://mwbn.bio/midwest-life-science-news/2024/07/25/lilly-confirms-date-and-conference-call-for-second-quarter-2024-financial-results-announcement/?utm_source=rss&utm_medium=rss&utm_campaign=otsuka-and-lundbeck-present-new-rexulti-brexpiprazole-post-hoc-efficacy-data-analyses-for-agitation-associated-with-dementia-due-to-alzheimers-disease-at-alzheimers-associati
| Whois | mwbn.bio |
| 68 | https://mwbn.bio/midwest-life-science-news/2024/07/25/the-medical-university-of-south-carolina-becomes-first-in-south-carolina-to-adopt-molli-surgicals-advanced-breast-cancer-technology/?utm_source=rss&utm_medium=rss&utm_campaign=otsuka-and-lundbeck-present-new-rexulti-brexpiprazole-post-hoc-efficacy-data-analyses-for-agitation-associated-with-dementia-due-to-alzheimers-disease-at-alzheimers-associati
| Whois | mwbn.bio |
| 69 | https://mwbn.bio/midwest-life-science-news/2024/07/24/republican-led-states-cant-intervene-in-case-on-abortion-pill-restrictions-appeals-court-says/?utm_source=rss&utm_medium=rss&utm_campaign=otsuka-and-lundbeck-present-new-rexulti-brexpiprazole-post-hoc-efficacy-data-analyses-for-agitation-associated-with-dementia-due-to-alzheimers-disease-at-alzheimers-associati
| Whois | mwbn.bio |
| 70 | https://mwbn.bio/midwest-life-science-news/2024/07/24/pbms-battle-bipartisan-scrutiny-as-lawmakers-eye-reforms/?utm_source=rss&utm_medium=rss&utm_campaign=otsuka-and-lundbeck-present-new-rexulti-brexpiprazole-post-hoc-efficacy-data-analyses-for-agitation-associated-with-dementia-due-to-alzheimers-disease-at-alzheimers-associati
| Whois | mwbn.bio |
| 71 | https://bcbn.org/boston-cambridge-biotech-news/2024/07/29/harvard-spinout-gets-45m-for-ultra-sensitive-blood-testing-tech/?utm_source=rss&utm_medium=rss&utm_campaign=quanterix-to-report-second-quarter-2024-financial-results
| Whois | bcbn.org |
| 72 | https://bcbn.org/boston-cambridge-biotech-news/2024/07/26/after-ftc-involvement-heres-when-abbvie-cerevel-deal-could-close/?utm_source=rss&utm_medium=rss&utm_campaign=quanterix-to-report-second-quarter-2024-financial-results
| Whois | bcbn.org |
| 73 | https://bcbn.org/boston-cambridge-biotech-news/2024/07/25/analog-devices-flagship-team-up-to-create-digital-biology-startups/?utm_source=rss&utm_medium=rss&utm_campaign=quanterix-to-report-second-quarter-2024-financial-results
| Whois | bcbn.org |
| 74 | https://bcbn.org/boston-cambridge-biotech-news/2024/07/22/boston-biotech-says-sec-may-take-enforcement-action-against-it/?utm_source=rss&utm_medium=rss&utm_campaign=quanterix-to-report-second-quarter-2024-financial-results
| Whois | bcbn.org |
| 75 | https://bcbn.org/boston-cambridge-biotech-news/2024/07/19/gro-bio-gathers-60m-series-b-to-take-gout-rival-to-krystexxa-into-clinic/?utm_source=rss&utm_medium=rss&utm_campaign=quanterix-to-report-second-quarter-2024-financial-results
| Whois | bcbn.org |
| 76 | https://bcbn.org/boston-cambridge-biotech-news/2024/07/16/alzheimers-biotech-asceneuron-raises-100m-to-see-if-it-can-compete-with-lilly-biogen-on-tau/?utm_source=rss&utm_medium=rss&utm_campaign=quanterix-to-report-second-quarter-2024-financial-results
| Whois | bcbn.org |
| 77 | https://bcbn.org/boston-cambridge-biotech-news/2024/06/21/questioning-milks-supremacy-in-school-lunchrooms/?utm_source=rss&utm_medium=rss&utm_campaign=quanterix-to-report-second-quarter-2024-financial-results
| Whois | bcbn.org |
| 78 | https://bcbn.org/boston-cambridge-biotech-news/2024/06/18/mit-graduate-engineering-and-business-programs-ranked-highly-by-u-s-news-for-2024-25/?utm_source=rss&utm_medium=rss&utm_campaign=quanterix-to-report-second-quarter-2024-financial-results
| Whois | bcbn.org |
| 79 | https://bcbn.org/boston-cambridge-biotech-news/2024/01/09/linkedup-bioscience-and-tianti-biotherapeutics-successfully-resolve-legal-dispute-with-adimab/?utm_source=rss&utm_medium=rss&utm_campaign=quanterix-to-report-second-quarter-2024-financial-results
| Whois | bcbn.org |
| 80 | https://bcbn.org/boston-cambridge-biotech-news/2024/01/09/jpm24-ultragenyx-nears-50m-series-a-for-its-alzheimers-gene-therapy-spinout/?utm_source=rss&utm_medium=rss&utm_campaign=quanterix-to-report-second-quarter-2024-financial-results
| Whois | bcbn.org |
| 81 | https://dcbn.org/dc-maryland-virginia-biotech-news/2024/07/29/metro-montgomery-county-partner-for-major-north-bethesda-development/?utm_source=rss&utm_medium=rss&utm_campaign=theriva-biologics-receives-rare-pediatric-drug-designation-by-the-u-s-fda-for-vcn-01-for-the-treatment-of-retinoblastoma
| Whois | dcbn.org |
| 82 | https://dcbn.org/dc-maryland-virginia-biotech-news/2024/07/29/indivior-reaches-86m-settlement-over-its-alleged-role-in-the-opioid-epidemic/?utm_source=rss&utm_medium=rss&utm_campaign=theriva-biologics-receives-rare-pediatric-drug-designation-by-the-u-s-fda-for-vcn-01-for-the-treatment-of-retinoblastoma
| Whois | dcbn.org |
| 83 | https://dcbn.org/dc-maryland-virginia-biotech-news/2024/07/28/fnih-biomarkers-consortium-announces-study-results-further-validating-blood-tests-for-alzheimers-disease/?utm_source=rss&utm_medium=rss&utm_campaign=theriva-biologics-receives-rare-pediatric-drug-designation-by-the-u-s-fda-for-vcn-01-for-the-treatment-of-retinoblastoma
| Whois | dcbn.org |
| 84 | https://dcbn.org/dc-maryland-virginia-biotech-news/2024/07/26/fda-roundup-july-26-2024/?utm_source=rss&utm_medium=rss&utm_campaign=theriva-biologics-receives-rare-pediatric-drug-designation-by-the-u-s-fda-for-vcn-01-for-the-treatment-of-retinoblastoma
| Whois | dcbn.org |
| 85 | https://dcbn.org/dc-maryland-virginia-biotech-news/2024/07/26/cel-sci-announces-pricing-of-10-8-million-offering/?utm_source=rss&utm_medium=rss&utm_campaign=theriva-biologics-receives-rare-pediatric-drug-designation-by-the-u-s-fda-for-vcn-01-for-the-treatment-of-retinoblastoma
| Whois | dcbn.org |
| 86 | https://dcbn.org/dc-maryland-virginia-biotech-news/2024/07/26/westlakes-non-opioid-pain-startup-latigo-gets-new-leader-ron-cooper-lands-next-ceo-gig-at-engene/?utm_source=rss&utm_medium=rss&utm_campaign=theriva-biologics-receives-rare-pediatric-drug-designation-by-the-u-s-fda-for-vcn-01-for-the-treatment-of-retinoblastoma
| Whois | dcbn.org |
| 87 | https://dcbn.org/dc-maryland-virginia-biotech-news/2024/07/25/glycomimetics-announces-strategic-review-and-corporate-restructuring-plan/?utm_source=rss&utm_medium=rss&utm_campaign=theriva-biologics-receives-rare-pediatric-drug-designation-by-the-u-s-fda-for-vcn-01-for-the-treatment-of-retinoblastoma
| Whois | dcbn.org |
| 88 | https://dcbn.org/dc-maryland-virginia-biotech-news/2024/07/24/revolo-announces-new-data-further-validating-the-upstream-mechanism-of-action-and-subcutaneous-administration-of-1104/?utm_source=rss&utm_medium=rss&utm_campaign=theriva-biologics-receives-rare-pediatric-drug-designation-by-the-u-s-fda-for-vcn-01-for-the-treatment-of-retinoblastoma
| Whois | dcbn.org |
| 89 | https://dcbn.org/dc-maryland-virginia-biotech-news/2024/07/24/behavioral-framework-acquires-behavior-consultation-psychological-services-bcps/?utm_source=rss&utm_medium=rss&utm_campaign=theriva-biologics-receives-rare-pediatric-drug-designation-by-the-u-s-fda-for-vcn-01-for-the-treatment-of-retinoblastoma
| Whois | dcbn.org |
| 90 | https://dcbn.org/dc-maryland-virginia-biotech-news/2024/07/17/serviam-care-network-and-bickford-senior-living-unite-to-bring-value-based-care-health-model-to-virginia-communities/?utm_source=rss&utm_medium=rss&utm_campaign=theriva-biologics-receives-rare-pediatric-drug-designation-by-the-u-s-fda-for-vcn-01-for-the-treatment-of-retinoblastoma
| Whois | dcbn.org |
| 91 | https://fgbn.org/florida-georgia-biotech-news/2024/07/26/sanofis-immunology-bet-starts-to-pay-off/?utm_source=rss&utm_medium=rss&utm_campaign=life-is-a-celebration-at-the-award-winning-watercrest-myrtle-beach-assisted-living-and-memory-care-community
| Whois | fgbn.org |
| 92 | https://fgbn.org/florida-georgia-biotech-news/2024/07/26/immorta-bio-files-investigational-new-drug-application-for-first-in-class-senolytic-immunotherapy-senovax-for-treatment-of-advanced-lung-cancer/?utm_source=rss&utm_medium=rss&utm_campaign=life-is-a-celebration-at-the-award-winning-watercrest-myrtle-beach-assisted-living-and-memory-care-community
| Whois | fgbn.org |
| 93 | https://fgbn.org/florida-georgia-biotech-news/2024/07/25/terran-orbitals-new-94000-square-foot-space-vehicle-assembly-facility-in-irvine-ca-receives-certificate-of-occupancy/?utm_source=rss&utm_medium=rss&utm_campaign=life-is-a-celebration-at-the-award-winning-watercrest-myrtle-beach-assisted-living-and-memory-care-community
| Whois | fgbn.org |
| 94 | https://fgbn.org/florida-georgia-biotech-news/2024/07/25/a-look-at-techs-olympic-past/?utm_source=rss&utm_medium=rss&utm_campaign=life-is-a-celebration-at-the-award-winning-watercrest-myrtle-beach-assisted-living-and-memory-care-community
| Whois | fgbn.org |
| 95 | https://fgbn.org/florida-georgia-biotech-news/2024/07/25/stuart-therapeutics-inc-announces-key-addition-to-its-executive-team/?utm_source=rss&utm_medium=rss&utm_campaign=life-is-a-celebration-at-the-award-winning-watercrest-myrtle-beach-assisted-living-and-memory-care-community
| Whois | fgbn.org |
| 96 | https://fgbn.org/florida-georgia-biotech-news/2024/07/25/tampa-pharma-company-stacked-with-former-mckesson-execs-launches-ipo/?utm_source=rss&utm_medium=rss&utm_campaign=life-is-a-celebration-at-the-award-winning-watercrest-myrtle-beach-assisted-living-and-memory-care-community
| Whois | fgbn.org |
| 97 | https://fgbn.org/florida-georgia-biotech-news/2024/07/17/rcx-sports-launches-foundation-to-promote-diversity-equity-and-inclusion-in-youth-sports/?utm_source=rss&utm_medium=rss&utm_campaign=life-is-a-celebration-at-the-award-winning-watercrest-myrtle-beach-assisted-living-and-memory-care-community
| Whois | fgbn.org |
| 98 | https://fgbn.org/florida-georgia-biotech-news/2024/07/17/manufacturing-investment-firm-bioprocess360-launches-with-100m-for-manufacturing-tech-companies/?utm_source=rss&utm_medium=rss&utm_campaign=life-is-a-celebration-at-the-award-winning-watercrest-myrtle-beach-assisted-living-and-memory-care-community
| Whois | fgbn.org |
| 99 | https://fgbn.org/florida-georgia-biotech-news/2024/07/16/connect-life-sciences-welcomes-mark-smith-and-jerick-henley-to-its-board-of-directors/?utm_source=rss&utm_medium=rss&utm_campaign=life-is-a-celebration-at-the-award-winning-watercrest-myrtle-beach-assisted-living-and-memory-care-community
| Whois | fgbn.org |
| 100 | https://fgbn.org/florida-georgia-biotech-news/2024/07/10/hearusa-delivers-dallas-area-residents-access-to-better-hearing-health-with-opening-of-a-new-hearing-center-of-the-future-in-keller-texas/?utm_source=rss&utm_medium=rss&utm_campaign=life-is-a-celebration-at-the-award-winning-watercrest-myrtle-beach-assisted-living-and-memory-care-community
| Whois | fgbn.org |
| 101 | https://ncbn.bio/north-carolina-biotech-news/2024/07/30/pfizer-weighs-sale-of-north-carolina-manufacturing-plant/?utm_source=rss&utm_medium=rss&utm_campaign=wellcare-of-north-carolina-and-expressable-expand-advanced-speech-therapy-program-across-the-state
| Whois | ncbn.bio |
| 102 | https://ncbn.bio/north-carolina-biotech-news/2024/07/30/pfizer-ups-2024-guidance-by-1b-after-multiple-rounds-of-cost-cuts/?utm_source=rss&utm_medium=rss&utm_campaign=wellcare-of-north-carolina-and-expressable-expand-advanced-speech-therapy-program-across-the-state
| Whois | ncbn.bio |
| 103 | https://ncbn.bio/north-carolina-biotech-news/2024/07/29/pfizer-cuts-210-north-carolina-workers-after-it-officially-discontinues-failed-duchenne-gene-therapy/?utm_source=rss&utm_medium=rss&utm_campaign=wellcare-of-north-carolina-and-expressable-expand-advanced-speech-therapy-program-across-the-state
| Whois | ncbn.bio |
| 104 | https://ncbn.bio/north-carolina-biotech-news/2024/07/29/vtv-therapeutics-diabetes-drug-program-hit-with-clinical-hold-from-fda/?utm_source=rss&utm_medium=rss&utm_campaign=wellcare-of-north-carolina-and-expressable-expand-advanced-speech-therapy-program-across-the-state
| Whois | ncbn.bio |
| 105 | https://ncbn.bio/north-carolina-biotech-news/2024/07/29/fda-places-vtvs-lead-diabetes-drug-on-hold-over-chromatographic-signal/?utm_source=rss&utm_medium=rss&utm_campaign=wellcare-of-north-carolina-and-expressable-expand-advanced-speech-therapy-program-across-the-state
| Whois | ncbn.bio |
| 106 | https://ncbn.bio/north-carolina-biotech-news/2024/07/27/mapping-glp-1-game-plans-q2-earnings-highlights-j-and-more/?utm_source=rss&utm_medium=rss&utm_campaign=wellcare-of-north-carolina-and-expressable-expand-advanced-speech-therapy-program-across-the-state
| Whois | ncbn.bio |
| 107 | https://ncbn.bio/north-carolina-biotech-news/2024/07/26/pfizer-to-lay-off-hundreds-of-workers-at-nc-plants-in-sanford-rocky-mount/?utm_source=rss&utm_medium=rss&utm_campaign=wellcare-of-north-carolina-and-expressable-expand-advanced-speech-therapy-program-across-the-state
| Whois | ncbn.bio |
| 108 | https://ncbn.bio/north-carolina-biotech-news/2024/07/26/pfizer-to-layoff-hundreds-at-north-carolina-facilities/?utm_source=rss&utm_medium=rss&utm_campaign=wellcare-of-north-carolina-and-expressable-expand-advanced-speech-therapy-program-across-the-state
| Whois | ncbn.bio |
| 109 | https://ncbn.bio/north-carolina-biotech-news/2024/07/26/maryland-real-estate-firm-splashes-into-triangle-with-27-6m-buy/?utm_source=rss&utm_medium=rss&utm_campaign=wellcare-of-north-carolina-and-expressable-expand-advanced-speech-therapy-program-across-the-state
| Whois | ncbn.bio |
| 110 | https://ncbn.bio/north-carolina-biotech-news/2023/07/24/novan-ceo-paula-brown-stafford-details-bankruptcy-decision/?utm_source=rss&utm_medium=rss&utm_campaign=wellcare-of-north-carolina-and-expressable-expand-advanced-speech-therapy-program-across-the-state
| Whois | ncbn.bio |
| 111 | https://pnbn.org/pennsylvania-ny-nj-biotech-news/2024/07/30/imunon-shares-up-over-150-as-ovarian-cancer-treatment-extends-survival-in-phase-2/?utm_source=rss&utm_medium=rss&utm_campaign=ocugen-inc-announces-proposed-public-offering-of-common-stock
| Whois | pnbn.org |
| 112 | https://pnbn.org/pennsylvania-ny-nj-biotech-news/2024/07/29/roivants-dealmaker-lands-81m-cash-bonus-following-drug-sale-to-roche/?utm_source=rss&utm_medium=rss&utm_campaign=ocugen-inc-announces-proposed-public-offering-of-common-stock
| Whois | pnbn.org |
| 113 | https://pnbn.org/pennsylvania-ny-nj-biotech-news/2024/07/29/boehringer-adds-to-cancer-drug-pipeline-with-deal-for-startup-nerio/?utm_source=rss&utm_medium=rss&utm_campaign=ocugen-inc-announces-proposed-public-offering-of-common-stock
| Whois | pnbn.org |
| 114 | https://pnbn.org/pennsylvania-ny-nj-biotech-news/2024/07/26/pfizer-and-biontech-say-gsks-covid-patent-suit-is-groundless/?utm_source=rss&utm_medium=rss&utm_campaign=ocugen-inc-announces-proposed-public-offering-of-common-stock
| Whois | pnbn.org |
| 115 | https://pnbn.org/pennsylvania-ny-nj-biotech-news/2024/07/26/fujirebio-launches-the-fully-automated-lumipulse-g-gfap-assay-for-research-use-only-and-further-strengthens-its-neuro-test-menu/?utm_source=rss&utm_medium=rss&utm_campaign=ocugen-inc-announces-proposed-public-offering-of-common-stock
| Whois | pnbn.org |
| 116 | https://pnbn.org/pennsylvania-ny-nj-biotech-news/2024/07/26/fda-approves-sun-pharmas-jak-inhibitor-leqselvi-for-hair-loss-in-adults/?utm_source=rss&utm_medium=rss&utm_campaign=ocugen-inc-announces-proposed-public-offering-of-common-stock
| Whois | pnbn.org |
| 117 | https://pnbn.org/pennsylvania-ny-nj-biotech-news/2024/07/25/abbvie-expects-8-7b-cerevel-buy-to-close-as-early-as-next-week-new-ceo-says/?utm_source=rss&utm_medium=rss&utm_campaign=ocugen-inc-announces-proposed-public-offering-of-common-stock
| Whois | pnbn.org |
| 118 | https://pnbn.org/pennsylvania-ny-nj-biotech-news/2024/07/22/layoffs-at-rapt-therapeutics-after-winding-down-mid-stage-trials-of-lead-drug/?utm_source=rss&utm_medium=rss&utm_campaign=ocugen-inc-announces-proposed-public-offering-of-common-stock
| Whois | pnbn.org |
| 119 | https://pnbn.org/pennsylvania-ny-nj-biotech-news/2024/07/19/hula-therapeutics-lands-250000-investment-for-winning-pennsylvania-biotech-center-pitch-competition/?utm_source=rss&utm_medium=rss&utm_campaign=ocugen-inc-announces-proposed-public-offering-of-common-stock
| Whois | pnbn.org |
| 120 | https://pnbn.org/pennsylvania-ny-nj-biotech-news/2024/07/19/pioneering-dermatologist-dr-anthony-benedetto-sells-practice-to-fast-growing-physician-group/?utm_source=rss&utm_medium=rss&utm_campaign=ocugen-inc-announces-proposed-public-offering-of-common-stock
| Whois | pnbn.org |
| 121 | http://twitter.com/biotechnetworks
| Whois | twitter.com |
| 122 | https://www.linkedin.com/company/biotech-networks/
| Whois | linkedin.com |
| 123 | https://www.youtube.com/c/SdbnOrg
| Whois | youtube.com |
| 124 | https://twitter.com/BiotechNetworks?ref_src=twsrc%5Etfw
| Whois | twitter.com |